Kirsten Hall Long, PhD
Articles
July 13th 2016
Economic and Clinical Impact of Routine Weekend Catheterization Services
Kirsten Hall Long, PhD James P. Moriarty, MSc Jeanine E. Ransom, BA Ryan J. Lennon, MS Verghese Mathew, MD Rajiv Gulati, MD, PhD Gurpreet S. Sandhu, MD, PhD Charanjit S. Rihal, MD, MBA
Weekend cardiac catheterization availability for inpatients reduced length of stay and maintained quality of care (no excess hazard for weekend cases), but costs were similar.
May 15th 2015
Costs of Venous Thromboembolism Associated With Hospitalization for Medical Illness
Kevin P. Cohoon, DO, MSc Cynthia L. Leibson, PhD Jeanine E. Ransom, BA Aneel A. Ashrani, MD, MS Tanya M. Petterson, MS Kirsten Hall Long, PhD Kent R. Bailey, PhD John A. Heit, MD
Venous thromboembolism during or after recent hospitalization for medical illness contributes a substantial economic burden to society across all hospital and ambulatory care delivered.
August 11th 2010
Clinical and Economic Outcomes After Introduction of Drug-Eluting Stents
Charanjit S. Rihal, MD, MBA James L. Ryan, MHA Mandeep Singh, MBBS Ryan J. Lennon, MS John F. Bresnahan, MD Juliette T. Liesinger, BA Bernard J. Gersh, MBChB, DPhil Henry H. Ting, MD, MBA David R. Holmes Jr, MD Kirsten Hall Long, PhD
Introduction of drug-eluting stents resulted in improved clinical outcomes for patients and reduced overall procedural costs.
Latest Updated Articles
Published: November 15th 2024 | Updated: November 19th 2024
FDA Approves Revumenib for R/R Acute Leukemia With a KMT2A Translocation
Published: April 1st 2024 | Updated: November 5th 2024
What We're Reading: Concierge Nonprofit Hospitals; Kaiser Permanente Elderly Care Program; Health Care Not Among Top Voter Issues
Published: October 21st 2024 | Updated: October 24th 2024
Lower Diagnostic Error Rates Found Among Hospitalized Patients During Care Transitions
Published: September 26th 2024 | Updated: October 1st 2024
Addressing Natural Disaster Takes Cooperation, Preparation to Ensure Patient Health
Published: May 9th 2024 | Updated: May 21st 2024
FDA Accepts Nivolumab Subcutaneous Injection Application, With Potential to Boost Access to PD-1 Inhibitors
Published: November 21st 2024 | Updated: November 23rd 2024
Polygenic Risk Scores Can Identify Patients Who Should Receive IOP-Lowering Treatment
